What’s New
We share news about new product features, our thoughts on recent developments at MedaSystems or in the industry at large. Scroll down for a chronological view, or jump to posts using the categories to the left.
The Biggest Challenges Facing Expanded Access Programs—and How Leading Pharmaceutical Companies Are Responding
As Expanded Access programs become more global and complex, pharmaceutical companies need scalable ways to manage requests, maintain compliance, and support patients faster.
Investigator-Initiated Studies (IIS) Trends in 2026
Investigator-Initiated Studies (IIS) are entering a transformative phase in 2026. As pharmaceutical companies, biotech firms, academic medical centers, and healthcare systems adapt to changing research demands, IIS programs are becoming more strategic, data-driven, patient-centered, and digitally enabled.
Why Expanded Access Programs Often Originate in Medical Affairs
Expanded Access Programs (EAPs) - also known as compassionate use—play a critical role in bridging the gap between clinical development and patient need.